Understanding how the HIV-1 virus integrates into cells
Role of the Viral Capsid in HIV-1 Integration
This study is looking at how a specific part of the HIV virus helps it enter and take over our cells, with the goal of finding new ways to create better treatments for people living with HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Meharry Medical College NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10436824 on NIH RePORTER |
What this research studies
This research investigates the role of the HIV-1 capsid protein in the process of viral integration into host cells. By examining how the capsid influences the virus's ability to infect and replicate, the study aims to identify new therapeutic targets for antiviral drugs. The approach involves functional studies of HIV-1 variants to understand the mechanisms behind viral integration and the stability of the capsid core. This could lead to the development of innovative treatments that are more effective and have fewer side effects than current options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV-1 who are seeking alternative treatment options beyond standard anti-retroviral therapy.
Not a fit: Patients who are not infected with HIV-1 or those who are already responding well to existing anti-retroviral therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral therapies that are more effective against HIV-1 and reduce the reliance on current expensive and side-effect-prone treatments.
How similar studies have performed: Other research has shown promise in targeting the HIV-1 capsid protein, indicating that this approach could lead to significant advancements in HIV treatment.
Where this research is happening
Nashville, United States
- Meharry Medical College — Nashville, United States (Active)
Researchers
- Principal investigator: Dash, Chandravanu — Meharry Medical College
- Study coordinator: Dash, Chandravanu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.